A detailed history of Pfm Health Sciences, LP transactions in Essa Pharma Inc. stock. As of the latest transaction made, Pfm Health Sciences, LP holds 2,742,936 shares of EPIX stock, worth $4.72 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
2,742,936
Previous 2,965,442 7.5%
Holding current value
$4.72 Million
Previous $15.6 Million 6.56%
% of portfolio
0.97%
Previous 0.8%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.45 - $7.1 $990,151 - $1.58 Million
-222,506 Reduced 7.5%
2,742,936 $16.6 Million
Q2 2024

Aug 14, 2024

SELL
$4.63 - $8.42 $69,348 - $126,114
-14,978 Reduced 0.5%
2,965,442 $15.6 Million
Q1 2024

May 14, 2024

SELL
$6.17 - $10.65 $1.74 Million - $3 Million
-282,080 Reduced 8.65%
2,980,420 $25.3 Million
Q4 2023

Feb 14, 2024

SELL
$2.74 - $7.35 $2.57 Million - $6.89 Million
-936,753 Reduced 22.31%
3,262,500 $21.5 Million
Q3 2023

Nov 14, 2023

SELL
$2.65 - $3.31 $15,105 - $18,867
-5,700 Reduced 0.14%
4,199,253 $13 Million
Q2 2023

Aug 14, 2023

BUY
$2.6 - $3.34 $113,079 - $145,263
43,492 Added 1.05%
4,204,953 $11.4 Million
Q1 2023

May 15, 2023

BUY
$2.56 - $3.55 $811,850 - $1.13 Million
317,129 Added 8.25%
4,161,461 $12.4 Million
Q4 2022

Feb 14, 2023

BUY
$1.5 - $4.82 $3.55 Million - $11.4 Million
2,366,080 Added 160.06%
3,844,332 $9.69 Million
Q3 2022

Nov 14, 2022

BUY
$1.75 - $3.44 $903,938 - $1.78 Million
516,536 Added 53.71%
1,478,252 $2.69 Million
Q2 2022

Aug 15, 2022

BUY
$3.15 - $7.94 $3.03 Million - $7.64 Million
961,716 New
961,716 $3.03 Million

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $75.8M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.